Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES COMPRISING AN AMPA RECEPTOR ENDOCYTOSIS INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2013/070011
Kind Code:
A1
Abstract:
Disclosed are a method or composition for the prevention or treatment of a neurological disease, comprising an AMPA endocytosis inhibitor. The present invention is useful as an agent for the prevention or treatment of various neurological diseases, for example neurodegenerative diseases, for example Alzheimer's disease and other such diseases, by inhibiting spine/synapse loss via AMPA receptor endocytosis inhibition.

Inventors:
CHOI SUKWOO (KR)
HONG INGIE (KR)
Application Number:
PCT/KR2012/009444
Publication Date:
May 16, 2013
Filing Date:
November 09, 2012
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SNU R&DB FOUNDATION (KR)
International Classes:
A61K38/17; A61K38/00; A61K38/16; A61P25/28
Foreign References:
US20060234912A12006-10-19
Other References:
BELL, J.D. ET AL.: "Mild in vitro trauma induces rapid Glur2 endocytosis, robustly augments calcium permeability and enhances susceptibility to secondary excitotoxic insult in cultured Purkinje cells", BRAIN, vol. 130, 2007, pages 2528 - 2542
HUANG, C.-C. ET AL.: "Rapl-induced p38 Mitogen-activated Protein Kinase Activation Facilitates AMPA Receptor Trafficking via the GDIRab5 Complex", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 13, 26 March 2004 (2004-03-26), pages 12286 - 12292
Attorney, Agent or Firm:
PARK, Weonmee (412 Nonhyeon-roGangnam-gu, Seoul 138-715, KR)
Download PDF:
Claims: